Advantage Alpha Capital Partners LP Sells 31,005 Shares of Encompass Health Corporation $EHC

Advantage Alpha Capital Partners LP lowered its position in shares of Encompass Health Corporation (NYSE:EHC) by 52.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,858 shares of the company’s stock after selling 31,005 shares during the quarter. Advantage Alpha Capital Partners LP’s holdings in Encompass Health were worth $3,416,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Pinnacle Wealth Planning Services Inc. lifted its stake in shares of Encompass Health by 4.0% during the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock valued at $263,000 after buying an additional 99 shares in the last quarter. Securian Asset Management Inc. lifted its position in shares of Encompass Health by 1.3% in the second quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock valued at $946,000 after acquiring an additional 100 shares in the last quarter. State of Michigan Retirement System boosted its stake in shares of Encompass Health by 0.4% in the second quarter. State of Michigan Retirement System now owns 24,245 shares of the company’s stock worth $2,973,000 after acquiring an additional 100 shares during the period. Caitong International Asset Management Co. Ltd grew its position in shares of Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after purchasing an additional 115 shares in the last quarter. Finally, UMB Bank n.a. lifted its holdings in Encompass Health by 10.9% in the 2nd quarter. UMB Bank n.a. now owns 1,187 shares of the company’s stock worth $146,000 after purchasing an additional 117 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Up 0.1%

Shares of EHC stock opened at $116.36 on Friday. The company has a market cap of $11.71 billion, a PE ratio of 22.00, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $127.99. The stock’s 50 day simple moving average is $120.62 and its two-hundred day simple moving average is $119.51. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The firm had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is 14.37%.

Analyst Upgrades and Downgrades

EHC has been the topic of several recent analyst reports. Bank of America lifted their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Barclays increased their price objective on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, November 23rd. Finally, Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, Encompass Health presently has an average rating of “Buy” and an average target price of $142.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.